Detalhe da pesquisa
1.
Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial.
Clin Infect Dis
; 75(1): e491-e498, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34467402
2.
Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag.
Blood
; 133(24): 2575-2585, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30992268
3.
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
N Engl J Med
; 376(16): 1540-1550, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423296
4.
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.
Blood
; 131(21): 2357-2366, 2018 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483101
5.
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
J Immunol
; 201(7): 1967-1974, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104242
6.
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
Blood
; 129(11): 1469-1479, 2017 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049639
7.
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.
Blood
; 126(19): 2213-9, 2015 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26337493
8.
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.
Lancet Oncol
; 16(2): 169-76, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25555420
9.
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib.
Haematologica
; 100(12): 1571-8, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26430171
10.
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017151
11.
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis.
Blood Cancer Discov
; 2(4): 319-325, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258102
12.
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.
Leuk Lymphoma
; 62(8): 1816-1827, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653216
13.
Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors.
Leuk Lymphoma
; 61(10): 2375-2382, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32508208
14.
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.
Blood Adv
; 4(8): 1700-1710, 2020 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32330244
15.
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia.
Blood Adv
; 4(2): 367-379, 2020 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31985806
16.
Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia.
Haematologica
; 94(9): 1266-73, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19734418
17.
Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.
Leukemia
; 31(6): 1340-1347, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28074063
18.
Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia.
JAMA Dermatol
; 152(6): 698-701, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26982511
19.
Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy.
Clin Cancer Res
; 22(1): 86-95, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26283682
20.
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.
Clin Cancer Res
; 22(7): 1572-82, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26660519